News

Oral antiviral nirmatrelvir/ritonavir is shown to be effective treatment for seniors against Omicron.

A biotech company is utilizing this platform to rid people of the virus using a technology that differs from CRISPR-Cas9.

Dentists write about 25.7 million prescriptions annually, amounting to about 10% of all outpatient antibiotic prescriptions in the United States. A recent study showed that educating dentists about the risks of antibiotics—including antimicrobial resistance and Clostridioides difficile infections—led to sharp decreases in prescriptions.

AIVITA’s COVID-19 vaccine candidate contains only the subject’s primed immune cells.

The young adult contracting paralytic polio in Rockland County, New York in June is the first since the WHO declared the Americas polio-free in 1994.

2 Washington, DC monkeypox patients presented with lesions and proctitis, and were treated with oral tecovirimat.

The Cambridge-MA., company accuses Pfizer and BioNTech of copying patented technology in the development of their COVID-19 vaccine.

Pfizer-BioNTech and Moderna have developed new booster shots optimized for Omicron. They could be approved as soon as Labor Day.

From its results, the company plans to file a Biologics License Application (BLA) with the FDA.

Rates of hepatitis C reinfection were low among people receiving opioid agonist therapy, according to a new study, which highlights the importance of risk reduction interventions and HCV treatment for people who inject drugs and people receiving opioid agonist therapy.

If granted the Emergency Use Authorization (EUA), this vaccine would be available for individuals 18 years and older.

Read this week’s top infectious disease stories you may have missed, including Dr. Anthony Fauci’s announcement.

Everyone in this industry have experienced a profound sense of exhaustion, trauma, grief, fear, and frustration. Surgeon General Vivek Murthy, MD, continues to make this issue a priority with a recent article.

The European Commission approved lenacapavir to treat multidrug-resistant HIV infection. The long-acting HIV treatment regimen will be marketed as Sunlenca and available in injection or tablet form.

The companies are requesting the Emergency Use Authorization (EUA) for 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older.

Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."

A third dose of mRNA COVID-19 vaccines may allow most immune compromised patients with hematologic cancers to achieve antibody response levels similar to those of healthy adults after a two-dose series.

WHO guidelines on HIV, hepatitis and STIs focus on populations with high risk of infections but low inclusion in prevention and treatment programs.

56% of adults with evidence of Omicron seropositivity did not know they were infected.

WHO issues new HCV treatment recommendations that include "radical simplification" of care pathways, in pursuit of testing and treatment goals.

Durable immune responses are seen in all age groups, even with significant discrepancies in antibody levels between children and adults.

CDC links 2021 outbreak of tuberculosis in US affecting 113 persons and causing at least 3 deaths to bone grafts from one infected, deceased donor.

Risk of severe maternal morbidity was highest during the period when Delta was the predominant COVID-19 variant.

The study was longitudinal in nature, comparing at-risk people who became infected with HIV to at-risk people who did not.

Home Run Inn Frozen Foods sausage pizzas have been recalled after consumers reported finding metal in the pizza.

If it is granted an Emergency Use Authorization (EUA), the vaccine could be used as a booster dose for individuals 18 years and older vaccinated with any of the other available COVID-19 vaccines.

Investigators sought to address the effectiveness of vaccination after COVID-19 recovery.

6 months after acute COVID-19 infection, patients had elevated usage of health care services to treat post-COVID conditions.